Treatment of Non-bacterial Thrombotic Endocarditis in Potentially Curable Cancer

Non-bacterial thrombotic endocarditis (NBTE) in a patient with a potentially curable malignancy poses a distinct clinical challenge. Management requires coordinating cardiac and oncological priorities before the opportunity for cancer cure is compromised.

Clinical Scenario

When NBTE occurs alongside a potentially curable cancer, coagulopathy correction and a multidisciplinary evaluation of surgical timing are central considerations — the cancer's curability directly shapes the risk-benefit calculus for any cardiac intervention.

Treatment Approach

Surgical intervention is part of the management framework for selected patients in this setting. Whether it is appropriate depends on the full clinical picture; the complete protocol specifies the conditions under which it is warranted.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.ejcts.2007.07.029

In patients with potentially curable cancer, coagulopathy should be corrected and a multidisciplinary approach regarding the priority of surgery should be considered.

If the patient is in acute congestive cardiac failure (due to valvular dysfunction) or occurrence of recurrent thromboembolism despite therapeutic anticoagulation then surgical intervention is warranted provided the complications and comorbid conditions does not make the prospect of recovery remote.

View source ↗